SCHEMBL13667553

SCHEMBL13667553

COc1cc2c(Cc3ccc(NS(=O)(=O)c4ccc(Cl)cc4F)cc3F)ccnc2cc1OCCCN1CCCCC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 16/20 0.64
▸ KIT P10721 4/20 0.60
▸ EGFR P00533 2/20 0.57
▸ MET P08581 2/20 0.57
▸ SRC P12931 2/20 0.57
▸ PLK4 O00444 1/20 0.57
▸ AURKA O14965 1/20 0.57
▸ GAK O14976 1/20 0.57
▸ RIPK2 O43353 1/20 0.57
▸ PRKAB2 O43741 1/20 0.57
▸ ERN1 O75460 1/20 0.57
▸ STK10 O94804 1/20 0.57
▸ MAP4K4 O95819 1/20 0.57
▸ FYN P06241 1/20 0.57
▸ YES1 P07947 1/20 0.57
▸ LYN P07948 1/20 0.57
▸ FER P16591 1/20 0.57
▸ MARK3 P27448 1/20 0.57
▸ MAP2K2 P36507 1/20 0.57
▸ TGFBR2 P37173 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12704883 0.90 AXL (0.62) AXLKITEGFRMETSRC
SCHEMBL1546565 0.88 AXL (0.82) AXLEGFRMETSRCPLK4
SCHEMBL13667704 0.84 AXL (0.68) AXLEGFRMETSRCPLK4
SCHEMBL10328511 0.83 AXL (0.49) AXLKITEGFRMETSRC
SCHEMBL13667703 0.83 AXL (0.79) AXLKITEGFRMETSRC
SCHEMBL13667484 0.83 AXL (0.74) AXLEGFRMETSRC
SCHEMBL1546915 0.82 AXL (0.88) AXLEGFRMETSRCPLK4
SCHEMBL1591402 0.81 AXL (0.82) AXLEGFRMETSRCPLK4
SCHEMBL13667535 0.81 AXL (0.66) AXLKITEGFRMETSRC
SCHEMBL12704879 0.81 AXL (0.79) AXLEGFRMETSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009127417-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2009-10-22 — — WO disclosed
Send feedback